Mirae Asset Global Investments »

Contineum Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 1.1k 11.43

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Palantir Technologies Cl A (PLTR)

View all positions for Mirae Asset Global Investments

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
Commodore Capital
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management

View all funds holding Contineum Therapeutics